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Summary: Determination of homocysteine in plasma or serum for evaluation of cobalamin and folate deficiency
is becoming an important diagnostic procedure. Accurate, rapid and low cost methods for measuring
homocysteine are therefore required. We have improved an HPLC method and made it suitable for clinical
application. The more important changes are the addition of an internal Standard, mercaptopropionylglycine,
and the use of a plasma/serum based calibration material. The method consists of the following steps:
reduction of the sample with tri-H-butylphosphine, precipitation of proteins, derivatisation with ammonium
7-fluorobenzo-2-oxa-l,3-diazole-4-sulphonate, and HPLC Separation followed by fluorescence detection. The
linearity of the assays is established and the coefficient of Variation is 3.0%. Stability studies show that blood
samples must be cooled or centrifuged immediately after venipuncture. The method is useful for evaluation
of cobalamin or folate deficiency, especially in patients with normal or moderately depressed cobalamin or
folate concentrations in blood.
Introduction *™<>/
 f^ u * · · i · jAbout 70% of the homocysteine in plasma is reported
Homocysteine is intimately related to methionine me- to be boünd to albumin (l, 2) and a variable amount
tabolism. It constitutes a link between the transmeth- is present äs mixed disulphides. To measure the total
ylation cycle where homocysteine is remethylated to homocysteine content (i. e., the sum of free homocy-
methionine and the transsülphuratiön pathway which steine and disulphide-bound homocysteine) the
catabolises homocysteine to sulphate. Cobalamin and plasma/serum sample is reduced with tri-w-butylphos-
folate defiency results in impaired homocysteine re- phine before protein precipitation. The content of free
methylation and homocysteinaemia. The increasing homocysteine can be measured by performing the
interest in measuring homocysteine is related to its reduction Step after protein precipitation.
correlation to the cobalamin and folate Status in pa-
tients deficieiit in pne of these $ubstances, and also to
its presumed role in arteriosclerotic cerebrovascular Materials and Methods
diseases. Recently, these and other subjects related to Reagents
homocysteine in plasma were reviewed by Ueland & Ammonium 7-fluorobenzo-2-oxa-l,3-diazole-4-sulphonate was
Refsum (1). obtained from Wako (Kyoto, Japan); Z)L-homocysteine, mer-
captopropionylglycine and tri-w-butylphosphine was from
Öuf method can be used in any laboratory equipped Sigma (St. Louis, MO, U. S, A.); cysteine and glutathione was
with an HPLC System, and all reagents are commer- from Mefck (Darmstadt, Germany). All other chemicals were
cially avalabile. Additon of mercaptopropionylglycme of analy^cal ßrade-
äs an internal Standard serves a double function in Apparatus
the assay — both äs a control for the derivatisation « . . , . « . , . r
 A -*u \A uJ
 , , . , - . „ , , Separation and quantification were performed with a Merck
reaction and äs a Standard for the size of the homo- Hitachi system (Pump 655A-12, LC Controller L-5000, fluo-
cysteine peak. ' rescence detector F-1050 and autosampler 655A-40) equipped
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with a Merck LiChrospher 100 RP-18 column (4 χ 125 mm,
5μιη particles) protected by a Merck LiChrospher 100 RP-18
guard column (4 χ 40 mm, 5 μπα particles). The fluorescence
intensities vvere measured with excitation at 385 nm and emis-
sion at 515 nm. The detection signal was recorded and the peak
areas quantified with a Merck Hitachi D-2000 integrator.
Chromatographie conditions
We used the gradient procedures described by Araki & Sako
(2). Although our column and HPLC System differs from theirs
and we observe shorter retention times, the procedures work
satisfactorily.
Buffer A: 0.1 mol/1 acetate buffer, pH 4.0, containing 20 ml/l
methanol (prepared from 0.1 mol/1 acetic acid and 0.1 mol/1
sodium acetate, approximately 600/1500).
Buffer B: 0.1 mol/1 phosphate buffer, pH 6.0, containing 50
ml/l methanol (prepared from 0.1 mol/1 sodium dihydrogen
phosphate and 0.1 mol/1 disodium hydrogen phosphate, ap-
proximately 625/125).
The buffers were filtered through a 0.45 μπι Millipore filter.
The linear gradient was run from solvent A to solvent B over
12.5 min (then 2.5 min B, a 3.0 min gradient back to A, and
2.0 min A Ipefore the next injection) at a flpw rate of 1.00 ml/
min. We also used an isocratic System, which was run for 20
min with solvent A at a flow rate of 1.00 ml/min.
Sample preparat ion
Plasma samples were obtained from about 3 ml of whole blood,
which were collected in a Venoject tube containing EDTA, then
immediately cooled on ice and centrifuged s soon s possible
at 3000 min"1 (2000 g) for 10 min at room temperature. Serum
was prepared from whole blood which was left to clot for
1Λ — 3Α hour at room temperature, then centrifuged. Specimens
were stored at 4 °C for analysis on the same day. Storage for
longer periods was at —20 °C.
One hundred and fifty microlitres of plasma/serum (sample or
calibration material) was mixed with 50 μΐ of buffer/standard
(0 or 0.2 mmol/1 homocysteine, 0.2 mmol/1 mercaptopropion^
ylglycine in 0.1 mol/1 potassium borate, pH 9.5, containing
2 mmol/1 EDTA). Twenty microlitres of 100 ml/l tri-/2-butyl-
phosphine in dimethylformamide were added, and the reduction
allowed to proceed for 30 min at 4 °C. Samples were then mixed
with 125 μΐ of 0.6 mol/1 perchloric acid, containing l mmol/1
EDTA, left at room temperature for 10 min, then centrifuged
at 13 000 min"1 (15 500 g) for 10 min. One hundred microlitres
were taken from the middle of the supernatant and mixed with
200 μΐ of 2 mol/1 potassium borate, pH 10.5, containing
5 mmol/1 EDTA. Ammonium 7-fluorobenzo-2-oxa-l,3-diazole-
4-sulphonate solution (100 μΐ) (1.0 g/l of 2 mol/1 potassium
borate, pH 9.5) were added and the mixture incubated at 60 °C
for 60 min. After cooling in an ice bath, the samples were ready
for HPLC. Ten microlitres of derivatised sample were used for
each injection.
Specimens
Blood was obtained in the morning from 16 apparently healthy
volunteers (eight men and eight women, aged 25-60 years).
All were in a good nutritional state with a normal protein
intake. None took drugs.
To test for possible interference from drugs, we measured homo^
cysteine in plasma samples from 60 patients who had received
various analgesic, antiepileptic, cardioactive, antipsychotic, an-
tibiotic or antineoplastic drugs.
Calibration and calculations
A two point calibration line was obtained from triplicate anal-
ysis of a plasma/serum pool, and of this pool spiked with 50
μιηοΐ/ΐ homocysteine. A linear regression line, with the added
homocysteine s the abcissa and the ratio between the area of
the homocysteine peak and the mercaptopropionylglycine peak
s the ordinate, was calculated to determine the slope of the
calibration line. The concentration'of homocysteine in the sana*
ples was then determined by dividing the ratio between the area
of the homocysteine peak and the mercaptopropionylglycine
peak by the slope of the calibration line.
The plasma and serum pools were stored s aliquots at —20 °C.
The homocysteine and the mercaptopropionylglycine Solutions
were kept s 0.4 mmol/1 aliquots at —20 °C.
Results and Discussion
Optimizing the assay conditions
In this work we have improved a method published
by Araki & Sako (2) and made it more suitable for
routine clinical use, The most important changes are
the use of a plasma/serum pool for calibration instead
of the buffer, and the addition of an internal Standard.
The use of a plasma/serurn pool is necessary because
the slope in the buffer calibration is less than in the
plasma/serum pool calibration. The addition of mer-
captopropionylglycine s an internal Standard serves
two p rposes, s a control of the derivatisation pro-
cedure and s a direct standardisation of the size of
the homocysteine peak. If the internal Standard mer-
captopropionylglycine is not added to the samples we
find that the total imprecision of the method approx-
imately doubles. Other technical changes are the use
of 150 μΐ of sample instead of the 500 μΐ used by the
previous method (2) and precipitation with perchloric
acid instead of trichloroacetic acid. In our System, the
use of perchloric acid instead of trichloroacetic acid
gives a better Separation of the peaks. As mentioned,
we also tried to run the samples with an isocratic
System to check whether HPLC Systems not equipped
with a gradient System can be used. The chrornato-
grams obtained in this way with buffer A only are
very similar to those from a gradient run, but we have
not checked the stability and the d rability of the
column under these conditions for a longer period.
Specificity
Derivatisation of the plasma/serum samples with the
thiol-specific reagent ammonium 7-fl orobeiizo^2-
oxa-l,3-diazole-4-sulphonate (3) results in a simple
chromatogram with a few well separated peaks s
shown in figure 1. The retention time for homocy-
steine is 3.2 min (SD = 0.032 min, CV = 1.0%,
n = 100) and for the internal Standard 15.1 min (SD
^= 0.16 min, CV = 1.1%, n F= 100).
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Fig. 1. HPLC chromatograms of ammonium 7-fluorobenzo-2-
oxa-l,3-diazole-4-sulphonate derivatised plasma with
added internal mercaptopropionylglycine Standard.
a) Plasma pool used for calibration.
b) Plasma pool with 50 μπιοΐ/ΐ homocysteine added.
The peaks at 3.36 min are the homocysteine and the
peaks at 15.68 and 15.72 are the mercaptopropionylgly-
cine Standard. The peaks at 2.45 min and 6.34 min are
cysteine and glutathione. The peaks at 4.27 min are
assigned to cysteinyl-glycine (2).
The homocysteine peak was identified by adding
homocysteine to the sample and observing an increase
of the symmetrical well-defined peak. In the same
way, we identified the peak with a retention time of
about 2.4 min s cysteine, and the peak at about 6.3
min s glutathione. By comparison with the original
work of Araki & Sako (2) we tentatively identify the
peak at about 4.3 min s cysteinyl-glycine.
When we analysed plasma samples from 60 patients
who had received various drugs, the chromatograms
did not reveal any interferences in the assay or the
appeafance of new peaks.
Calibration
Calibration lines prepared by the analysis of homo-
cysteine in 0.2 mol/1 potassium borate, pH 9.5, or in
a plasma pool showed different slopes (15% differ-
ence). Calibration must therefore be performed with
plasma/serum-based calibrators. This matrix effect
could be due to the presence of proteins, ionic strength
or some other spedes catalysing the derivatisation
Step. The Variation of the slope in different plasmas
was also investigated; the greatest Variation was 4%
and thus less than the difference between a plasma
pool and the buffer.
Recovery and l ineari ty
To investigate the recovery and linearity of the assay,
we added different concentrations of homocysteine to
both the plasma and serum pools. Homocysteine was
added to a plasma pool so s to increase its concen-
tration by 0,25, 50,100,200, 300,400 and 500 μπκ>1/1.
Linear regression analysis of the results gave
y = 0.0220 + 0.0124 χ with a correlation coefficient
of 0.999, where y is the ratio of the homocysteine
peak area divided by the mercaptopropionylglycine
peak area and χ is the increase in homocysteine con-
centration. The same experiment with serum gave
y = 0.1015 + 0.0136 χ with a correlation coefficient
of 1.000. Addition of 0, 5, 10, 25, 50 and 100 μπιοΐ/ΐ
to a plasma pool gave y = 11.65 + 0.823 χ with a
correlation coefficient of 0.999, where y is the ratio
of the homocysteine peak area and χ is the increase
in homocysteine concentration.
Plasma and serum samples were also diluted 1.2, 1.5,
2, 3, 6 and 12 times and plotted with χ s the amount
of sample and y s the homocysteine peak area di-
vided by the mercaptopropionylglycine peak area.
The resulting line is slightly curved s expected from
the dilution of the samples with a buffer with a 15%
lower standardisation slope.
If a patient sample contains so much homocysteine
that the chromatogram response goes off the scale (in
our System more than 500 μπιοΐ/ΐ), the injection sam-
ple can be diluted and chromatographed again and
recalculated by using the area of the mercaptopro-
pionylglycine peak multiplied by the dilution factor.
Detection limit
The sensitivity of the method when defined s a signal
to noise ratio ^ 5 is at least 0.3 μιηοΐ/ΐ homocysteine.
This value is in accordance with other HPLC methods
for measuring homocysteine (3, 4). Araki & Sako (2)
did not state a limit of detection for measuring total
homocysteine.
Precision
The total imprecision of the method was determined
by dividing a plasma sample into aliquots and deter-
mining the homocysteine concentration of each ali-
quot in duplicate over a period of four weeks. The
coefficient of Variation was 3.0% (mean = 8.92
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μιηοΐ/ΐ homocysteinc, n = 11). The within-run com-
ponent of imprecision was 2.3%. Araki & Sako (2)
did not report values which are directly comparable.
Furthermore, we divided a sample pool into ten ali-
quots which were assayed in one run. The coefficient
of Variation was 2.4% (mean = 10.94 μπιοΙ/1). The
major part of the variability is thus in the within-run
imprecision, implying a low day-to-day Variation.
The within-run imprecision of our method compares
favourably with those reported for other HPLC as-
says for homocysteine in plasma, namely 2.9% (3),
5.0% (4), and 3.8% (5). This improvement is probably
a result of the addition of the internal Standard.
Mercaptopropionylglycine has a high chemical resem-
blance to homocysteine although the retention time
for mercaptopropionylglycine is considerably higher
than for the homocysteine peak.
Stability studies
We investigated the effect of incubation of whole
blood at room temperature before Separation of
plasma or serum from cells. As depicted in figure 2,
a fresh blood sample left at room temperature without
centrifugation will show a considerable increase in
homocysteine concentration. This increase is linear
for at least 4 hours and amounts to 9 —10% per hour.
The relative increase after 24 hours varies significantly
from sample to sample. This increase in homocysteine
concentration can be eliminated by centrifugation fol-
lowed by pipetting of plasma/serum. After centrifu-
gation and pipetting the concentrations of homocy-
steine in the samples are stable, even at room tem-
perature, for at least 24 hours. Therefore, the blood
samples must be cooled or centrifuged immediately
after blood sampling.
We stored plasma/serum samples at —20 °C for three
months without any measurable change in the homo-
cysteine concentrations. Furthermore, one sample was
thawed and frozen nine times during one week and
each time an aliquot was removed and frozen. When
all samples were analysed in the same run, the hom-
ocysteine concentration was' 9.64 ± 0.19 μιηοΐ/ΐ
(mean ± SD) and the first and last values were 9,67
and 9.51, respectively.
The samples are also very stable after derivatisation
with ammonium 7-fluorobenzo-2-oxa-l,3-diazole-4-
sulphonate. They can be stored at 4°C for several
weeks. The samples may turn yellow because am-
monium 7-fluorobenzo-2-oxa-l ,3-diazole-4-sulphon^
ate is light sensitive. However, this does not seem to
cause any problems in the assay, but s a precaution
we kept the ammonium 7-fluorobenzo-2-oxa-l,3-dia-
zole-4-sulphonate solution in a cold and dark place
until use.
We did not filter the samples before injection into the
column because we found it more economical (both
in materials — the cost of one guard column equals
the cost of 20 filters — and working hours) to change
the small guard columns after abo t 75 sample injec-
tions.
The high increase of homocysteine in plasma/serum
when blood samples are left at room temperature is
an interesting problem. Cooling of the blood sample
followed by incubation at room temperatures does
not stop the increase of homocysteine in plasma/
serum. We measured the homocysteine concentration
in haemolysates of bloocl and in isotonic NaCl ineu-
bated with the residue of blood samples after removal
of plasma. These preliminary experiments indicate
that the homocysteine increase stems from a produc-
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Fig. 2. Incubation of whole blood at room temperature before Separation of plasma or serum from cells. The increases of
homocysteine when measured in plasma (a) or serum (b) specimens, are depicted. The res lts are the average of experiments
on five subjects. The error bars indicate ± SEM.
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Am Institut für Medianische Chemie und Biochemie der Medizinischen Fakultät gelangt eine Planstelle
eines/einer
Ordentlichen Universitätsprofessors/Universitätsprofessorin
für Medizinisch-Analytische Chemie
zur Besetzung.
Anstellungserfordernisse sind ein in- oder ausländisches facheinschlägiges Doktorat, eine in- oder
ausländische facheinschlägige Lehrbefugnis (venia docendi oder eine gleichzuhaltende wissenschaftliche
Befähigung) und der Nachweis der pädagogischen Eignung.
Ein Schwerpunkt des Institutes für Medizinische Chemie und Biochemie liegt in der Pteridinforschung.
Bewerber/Bewerberinnen sollen durch hervorragende Forschungsleistungen auf dem Gebiet der medi-
zinrelevanten Pteridinforschung ausgewiesen sein und eine besondere Bereitschaft zur Zusammenarbeit
im Rahmen der interdisziplinären Kooperation zwischen theoretischen und klinischen Institutionen der
Medizinischen Fakultät haben.
Von dem/der künftigen Universitätsprofessor/Universitätsprofessorin wird erwartet, daß er/sie das
Gesamtgebiet der Medizinischen Chemie gemeinsam mit dem Ordentlichen Universitätsprofessor für
Medizinische Chemie in der Lehre betreut.
Bewerbungen mit den üblichen Unterlagen (Lebenslauf, wissenschaftlicher Werdegang, bisherige Lehr-
tätigkeit zum Nachweis der pädagogischen Eignung, Aufstellung der Veröffentlichungen, internationale
Kooperationen usw.) sind bis spätestens 30. September 1991 an den Dekan der Medizinischen Fakultät
der Leopold-Franzens-Universität Innsbruck, Univ.-Prof. Dr. E. Bodner, Innrain 52, A-6020 Innsbruck,
zu richten.
O. Univ.-Prof. Dr. E. Bodner
Dekan
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Encyclopedia Biochemistry
Second Edition,
revised and expanded by Thomas Scott and Mary Eagleson
1988.17 cm 24 cm. 650 pages. Hardcover. DM 148,-; approx, US $89.00
ISBN 3110116251
 ; ,
The only single work of its kind in English, the Concise Encyclopedia of Biochemistry provides a
comprehensive, yet compact, source of biochemical data and Information for the researcher,
teacher, and Student.
Following a five-year program of collecting and editing new material, äs well äs the revision of
existing entries, the author-editors and the publishers are pleased to announce the new
expanded Second Edition of this valuable reference work.
Major entries concerning the latest developments in DNA stfucture, synthesis, sequencing,
binding proteins and methods, oncogenes, lymphokines and other newly discovered regulatory
peptides, structural proteins, inositol phosphates, and prötein kinases have been added. Graphic
Illustration has been given high priority, so that regulatory processes, transport, subcellular
structures, etc. are abundantly and clearly illustrated.
The coverage of plant biochemistry has also been greatly expanded. Anöther new addition is a
section on buffers which will be useful to anyone involved in laboratory work. Because of its
comprehensiveness and multidisciplinary nature, we are sure that you will find it an indispens-
able reference tool.
Special features of this edition include:
© Approximately 4,500 entries
O Up-to-date, comprehensive
© Coverage of medical, animal, microbial, plant, and physical biochemistry, natural products,
molecular biology, molecular genetics, and biotechnology
O Hundreds of illustrations, including structural formulas, schemes, and metabolic pathways
O Over 100 tables
O Modern terminology based on Standard sources, e. g., IUB Enzyme Nomenclature
O Standard biochemical abbreviations
O Extensive cross references with Synonyms provided
O Literature references are cited to aid the reader in locating original sources
Potential au dien ce: biochemists, clinical biochemists, clinical chemists, medical researchers, clini-
cians, plant scientists, experimental biologists, lecturefs and students of the life seiences.
Price is subject to change without notice
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Verlag Walter de Gruyter & Co., Genthiner Str. 13, D-1000 Berlin 30, Tel.: (030) 2 60 05-0, Telex 184 027
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The Roots of Modem Biochemistiry
Fritz Lipmann's Squiggle and its Consequences
Editors Horst Kleinkauf, Hans von Döhren, Lothar Jaenicke
1988. 17 cm 24 cm. XII, 988 pages. Numerous illustrations.
Hardcover. DM 448,-; approx. US $263.00 ISBN 311011585 9
A Fritz Lipmann dedicatory volume, originating from the Memorial
Meeting held in Berlin-Dahlem in 1987, presenting the major aspects
of modern biochemistry and their development in 90 essays. The
Warburg/Meyerhof era, the time of emigration and postwar science
are revived. Contemporaries and coworkers together with other
outstanding scientists describe the state of biochemistry in major
fields: äs it was, äs it is now, and where it will be going. At the
same time this volume is a reference book on Fritz Lipmann, the
outstanding biochemist, and life scientist, who considered his concept
of the energy-rich bond, symbolized by the squiggle, äs his major
achievement.
From the Contents
Fritz Lipmann 1899-1986 · Biochemistry Comes of Age ·
Molecular Biology Sharpens its Tools · Functional Dynamics:
The Squiggle-Symbol of Bioenergetics; Molecular Recognition and
Communication · Evolution · List of Contributors · Lipmann's
Coworkers at Massachusetts General Hospital, Boston, and the
Rockefeiler University, New York · Fritz Lipmann: Bibliography
1924-1985 · Author Index · Subject Index
Price is subject to change without notice
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alysensystems CH
Nur 1 Serum pro Bestimmung ist erforderlich -
mehr nicht! Weniger Serum bedeutet auch weniger
Reagenz. Jahr für Jahr fallen in der Bundesrepublik
durch klinisch-chemische Tests gut und gern
250.000 Liter Reagenzien an. 10 Tanklastzüge!
Diese Menge muß nicht nur gekauft werden, son-
dern auch ihre Entsorgung wird künftig durch
schärfere Vorschriften mit Sicherheit kostspieliger.
Der TECHNICON CHEM 1 von Bayer Diagnostic
kann die anfallenden Mengen um 95% senken!
Das ist neuer Umweltrekord! Die einzigartige
Kapselchemie mächt dies möglich. Die zu untersu-
chenden Patientenproben sind - wie das Gelbe im
Ei-von einem flüssigen Film umgeben, also einge-
kapselt. So ist eine gegenseitige Beeinflussung der
Proben ausgeschlossen und die Richtigkeit der Er-
gebnisse ist gewährleistet. Es zahlt sich aus, mehr
über den TECHNICON CHEM 1 zu wissen! Wir
informieren Sie gerne. Schreiben Sie uns bitte oder
senden Sie ein Fax an:
Bayer Diagnostic GmbH
Weißenseestraße 101
8000 München 90
Telefax 0 89/6 99 27-127
i··/:>>#·& ' ' > · . -'
Bayer Diagnostics
The Biologie
Dehydroepiandirosteroiie (DHEA)
Editors M. Y. Kalimi, W. Regelson
1990.17 cm 24 cm. VHI, 450 pages. Numerous illustrations and tables.
Hardcover DM 340,-; approx. US $220.00
ISBN 311012243 X
DHEA is a native steroid that declines with progressive age> and is foimd
in the brain at concentrations equal to that in the adrenal cortex. DHEA
acts äs a precursor steroid and/or a buffer Hormone that alters state depen-
dency by interacting with other hormones.
There is a growing interest in DHEA's clinical place in atherosclerosis,
hypertension, memory disorders, fat mobilization, and cancer prevention
treatment.
Experts from around the world have contributed to this volume. They
explain DHEA's broad actiqn and it's potential relevance to clinical
disease.
Price is subject to change without notice
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tion of homocysteine or a conversion of homocysteine
derivatives to homocysteine in the blood cells. This
matter will be further investigated.
Practicability
Whether it is preferable to use plasma or serum is
very dependent on the laboratory routines. We prefer
to use plasma, because although serurn can be used
if the reference r nge for healthy individuals is ad-
justed to it (tab. 1), it is impractical to keep control
of the clotting time and the following centrifugation.
The plasma method requires "a glass of ice at the
bedside" and although this is inconvenient it is man-
ageable.
Tab. l. Homocysteine concentration in μιηοΐ/ΐ, analysed in
plasma and serum obtained from the same venipunc-
ture. n = 8 for both men and women.
mean SD r nge
Plasma
men
women
Serum
men
women
9.8
6.8
10.8
7.6
1.6
1.2
1.6
1.2
7.8-11.9
5.5- 8.4
8.7-13.0
5.8- 9.1
About 50 tubes (calibrators + 22 samples in dupli-
cate) can easily be processed in one working day and
the samples can be analysed overnight. Use of the
assay for six months pr vided it to be a robust and
effective method, suitable for routine analysis.
We also used the method to determine free homocy-
steine in two samples (by precipitating the proteins
before reduction with tri^butylph sphine). The sam-
ples showed a free homocysteine coutent of 1.6 μιηοΐ/ΐ
and 1.7 μήιόΐ/ΐ homocysteine (6.1 μϊτιοΐ/ΐ and 6.9
μιηόΙ/1 in total homocysteine) which compare well
with the values reviewed by Ueland & Refsum (1).
Analysed blood samples
Plasma/serum homocysteine concentrations were
naeasured in blood samples from 16 apparently
healthy vplunteers. The plasma and the serum were
obtained from the same venipuncture, and the homo-
cysteine values were consistently higher (in average
10%) for all serum samples (p < 0.005, Wilcoxon test
for pair diff rences). Most of this difference can be
attributed to the different treatment of the blood
samples, plasma samples being cooled immediately,
whereas serum samples are left to clot at room tem-
perature for 1A — 3A h before centrifugation.
The homocysteine r nge has been reported to differ
between men and women ( s illustrated by the values
below) but also to be age-dependent; for further de-
tails see 1. c. (1). In general, men seem to have higher
concentrations of homocysteine than women, while
older people have higher concentrations than younger
people. Our data, which are summarized in table l,
support this difference between the homocysteine val-
ues in men and women (p < 0.005, Wilcoxon test for
two samples). Our values are a little higher than those
reported by Araki & Sako (2) who found 6.53 ± 1.08
μιηοΐ/ΐ homocysteine (mean ± SD) for men (n = 20),
and 5.71 ± 1.20 for women (n = 15), while they are
a little lower than the values reported by Brattstr m
et al. (6) who reported 12.1 ± 4.0 for men (n = 22)
and 8.9 ±1.0 for women (n = 10). Even higher val-
ues (7.2—21.7 μιηοΐ/ΐ homocysteine (mean + 2 SD),
20% higher in males than in females) have been
reported for serum samples (7). These differences can
probably be explained by the different handling of
the blood samples before Separation of plasma and
serum from cells and the various analytical methods
employed.
Finally, in plasma samples of two patients with de-
pressed concentrations of erythrocyte folate (188 and
301 nmol/1 respectively; reference r nge: 400 — 1200
nmol/1) we found increased concentrations of plasma
homocysteine, namely, 60.6 and 48.1 μιηοΐ/ΐ.
Conclusion
We have improved a method for measuring total
homocysteine in plasma and serum. The method uses
only commercially available reagents and requires
only a Standard HPLC apparatus equipped with a
fluorescence detector in addition to normal laboratory
equipment. The addition of an internal Standard en-
sures good precision, accuracy and performance. The
analysis is robust, fast and inexpensive and is now
suitable for routine use in the clinical laboratory.
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